{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:09:53Z","timestamp":1789610993516,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.leukres.2020.106408","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T15:16:24Z","timestamp":1593702984000},"page":"106408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Diminished expression of 5hmc in Reed-Sternberg cells in classical Hodgkin lymphoma is a common epigenetic marker"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0324-7557","authenticated-orcid":false,"given":"Andrew","family":"Siref","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Washington","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhan","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2020.106408_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrc2542","article-title":"The biology of Hodgkin\u2019s lymphoma","volume":"9","author":"K\u00fcppers","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2020.106408_bib0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.critrevonc.2012.07.002","article-title":"Hodgkin lymphoma","volume":"85","author":"Gobbi","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"8","key":"10.1016\/j.leukres.2020.106408_bib0015","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","article-title":"DNA methylation and human disease","volume":"6","author":"Robertson","year":"2005","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.leukres.2020.106408_bib0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jmb.2005.05.032","article-title":"Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines","volume":"350","author":"Doerr","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.leukres.2020.106408_bib0025","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2005-09-3765","article-title":"Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma","volume":"107","author":"Ushmorov","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2020.106408_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/leu.2011.194","article-title":"Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes","volume":"26","author":"Ammerpohl","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2020.106408_bib0035","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.leukres.2020.106408_bib0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00441-014-1896-7","article-title":"The role of 5-hydroxymethylcytosine in human cancer","volume":"356","author":"Pfeifer","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"22","key":"10.1016\/j.leukres.2020.106408_bib0045","doi-asserted-by":"crossref","first-page":"12767","DOI":"10.1074\/jbc.271.22.12767","article-title":"Cloning and expression of human G\/T mismatch-specific thymine-DNA glycosylase","volume":"271","author":"Neddermann","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2020.106408_bib0050","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cell.2008.11.042","article-title":"DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45","volume":"135","author":"Rai","year":"2008","journal-title":"Cell."},{"key":"10.1016\/j.leukres.2020.106408_bib0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2011.03.022","article-title":"Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain","volume":"145","author":"Guo","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.leukres.2020.106408_bib0060","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1229277","article-title":"Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine","volume":"339","author":"Hackett","year":"2013","journal-title":"Science."},{"issue":"5","key":"10.1016\/j.leukres.2020.106408_bib0065","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/onc.2012.67","article-title":"Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation","volume":"32","author":"Yang","year":"2013","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.leukres.2020.106408_bib0070","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-11-2023","article-title":"5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res."},{"issue":"September (9)","key":"10.1016\/j.leukres.2020.106408_bib0075","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cas.12484","article-title":"TET2 as an epigenetic master regulator for normal and malignant hematopoiesis","volume":"105","author":"Nakajima","year":"2014","journal-title":"Cancer Sci."},{"issue":"July (1)","key":"10.1016\/j.leukres.2020.106408_bib0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.leukres.2020.106408_bib0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3960\/jslrt.54.67","article-title":"Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine","volume":"54","author":"Matsuda","year":"2014","journal-title":"J. Clin. Exp. Hematop."},{"issue":"September (3)","key":"10.1016\/j.leukres.2020.106408_bib0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cmet.2015.06.009","article-title":"2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling","volume":"22","author":"Fu","year":"2015","journal-title":"Cell Metab."},{"issue":"March (6127)","key":"10.1016\/j.leukres.2020.106408_bib0095","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1231677","article-title":"(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible","volume":"339","author":"Losman","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.leukres.2020.106408_bib0100","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.leukres.2020.106408_bib0105","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"December (12)","key":"10.1016\/j.leukres.2020.106408_bib0110","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/2159-8290.CD-18-0657","article-title":"TET2 deficiency causes germinal center Hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis","volume":"8","author":"Dominguez","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.leukres.2020.106408_bib0115","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-11-2023","article-title":"5-hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2020.106408_bib0120","doi-asserted-by":"crossref","first-page":"26591","DOI":"10.1038\/srep26591","article-title":"Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.leukres.2020.106408_bib0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2010.10.038","article-title":"IDH1 and IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia but rare in other types of hematological disorders","volume":"402","author":"Zou","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"October (43)","key":"10.1016\/j.leukres.2020.106408_bib0130","doi-asserted-by":"crossref","first-page":"12202","DOI":"10.1073\/pnas.1608679113","article-title":"Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to na\u00efve pluripotency by complementary mechanisms","volume":"113","author":"Hore","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7461","key":"10.1016\/j.leukres.2020.106408_bib0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature12362","article-title":"Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells","volume":"500","author":"Blaschke","year":"2013","journal-title":"Nature"},{"issue":"December (6)","key":"10.1016\/j.leukres.2020.106408_bib0140","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ijc.2910260605","article-title":"Two neoplastic cell lines with unique features derived from Hodgkin\u2019s disease","volume":"26","author":"Schaadt","year":"1980","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.leukres.2020.106408_bib0145","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/onc.2012.67","article-title":"Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation","volume":"32","author":"Yang","year":"2013","journal-title":"Oncogene."},{"issue":"May (21)","key":"10.1016\/j.leukres.2020.106408_bib0150","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.0702854104","article-title":"Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo","volume":"104","author":"Chen","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"38","key":"10.1016\/j.leukres.2020.106408_bib0155","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"476","key":"10.1016\/j.leukres.2020.106408_bib0160","article-title":"Ascorbate regulates haematopoietic stem cell function and leukaemogenesis","volume":"549","author":"Agathocleous","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.leukres.2020.106408_bib0165","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"issue":"July (7)","key":"10.1016\/j.leukres.2020.106408_bib0170","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1038\/bcj.2017.65","article-title":"Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells","volume":"7","author":"Shenoy","year":"2017","journal-title":"Blood Cancer J."},{"issue":"July (28)","key":"10.1016\/j.leukres.2020.106408_bib0175","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1021\/ja4028346","article-title":"Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals","volume":"135","author":"Yin","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.leukres.2020.106408_bib0180","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.leukres.2020.106408_bib0185","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"issue":"November (11)","key":"10.1016\/j.leukres.2020.106408_bib0190","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/s41374-018-0096-6","article-title":"Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues","volume":"98","author":"Juskevicius","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.leukres.2020.106408_bib0195","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.exphem.2011.07.002","article-title":"The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors","volume":"1","author":"J\u00f3na","year":"2011","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2020.106408_bib0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3892\/ijo.2016.3827","article-title":"Activation of oncogenic pathways in classical Hodgkin lymphoma by decitabine: a rationale for combination with small molecular weight inhibitors","volume":"50","author":"Swerev","year":"2017","journal-title":"Int. J. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T22:38:55Z","timestamp":1736980735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212620301132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":40,"alternative-id":["S0145212620301132"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106408","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diminished expression of 5hmc in Reed-Sternberg cells in classical Hodgkin lymphoma is a common epigenetic marker","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106408"}}